Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 14.52 USD 0.76%
Market Cap: 400.8m USD
Have any thoughts about
ZimVie Inc?
Write Note

ZimVie Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ZimVie Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Z
ZimVie Inc
NASDAQ:ZIMV
Total Receivables
$65.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Receivables
$3B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Total Receivables
$2.5B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Total Receivables
$3.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Receivables
$6.9B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Receivables
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
16%
No Stocks Found

ZimVie Inc
Glance View

Market Cap
400.6m USD
Industry
Health Care

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

ZIMV Intrinsic Value
18.28 USD
Undervaluation 21%
Intrinsic Value
Price
Z

See Also

What is ZimVie Inc's Total Receivables?
Total Receivables
65.2m USD

Based on the financial report for Dec 31, 2023, ZimVie Inc's Total Receivables amounts to 65.2m USD.

What is ZimVie Inc's Total Receivables growth rate?
Total Receivables CAGR 3Y
-30%

Over the last year, the Total Receivables growth was -63%. The average annual Total Receivables growth rates for ZimVie Inc have been -30% over the past three years .

Back to Top